Tela Bio Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -46.3% | -65.0% | -86.6% | -66.5% | -47.4% | -42.7% | -52.5% | -39.1% | -27.6% | -23.3% | -58.6% | -48.6% | -39.0% | |
| 1.4% | 0.9% | 1.4% | 1.5% | 1.4% | 1.5% | 1.4% | 1.3% | 1.2% | 1.1% | 1.4% | 1.4% | 1.3% | |
| 9.1% | 7.3% | 6.6% | 6.8% | 5.7% | 6.2% | 5.6% | 4.9% | 4.6% | 3.9% | 4.3% | 3.2% | 4.0% | |
| 14.4% | 0.1% | -19.1% | 0.6% | -4.4% | -5.2% | -3.1% | 1.8% | 2.6% | 5.5% | -6.3% | 2.2% | 1.1% | |
| 0.9% | 1.2% | 1.8% | 1.9% | 0.6% | 1.5% | 0.2% | 0.6% | 1.0% | 0.4% | 0.6% | 0.3% | 0.6% | |
| -0.9% | -1.1% | 28.3% | 0.4% | -0.6% | -1.1% | 0.7% | 1.0% | 1.5% | 0.9% | 1.0% | 1.2% | 1.2% | |
| 0.0% | 0.0% | -2.0% | -0.1% | -0.1% | -0.1% | – | 0.0% | 0.5% | -0.6% | 0.1% | -0.5% | -0.1% | |
| 0.5% | 0.1% | 0.3% | 0.0% | 0.5% | 243.1% | -0.6% | 0.0% | 0.1% | 123.8% | -1.6% | -0.1% | 32.0% | |
| -46.9% | -65.9% | -57.7% | -66.2% | -48.5% | 200.4% | -53.1% | -38.9% | -25.4% | 101.3% | -59.3% | -47.5% | -5.8% | |
| -47.2% | -66.2% | -88.5% | -68.3% | -48.0% | -44.2% | -52.7% | -39.7% | -28.7% | -23.8% | -59.2% | -48.9% | -39.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.